May 15-16, 2023. T-CURX to participate at 2023 Bio€quity conference in Dublin, Ireland

T-CURX will attend and present at the 23rd Bio€quity conference in Dublin, Ireland

T-CURX, a new European Biotech company in the field of developing next-generation CAR-T cell therapies for cancer patients, will participate at the 23rd Bio€quity congress, taking place from May 15-16, 2023 at the Convention Centre Dublin (Spencer Dock, North Wall Quay, Dublin, Ireland). T-CURX CEO, Ulf Grawunder, will present T-CURX strategies and plans to provide better, more cost-effective and highly scalable CAR-T therapies for cancer patients in the Biotech presentation stream of the European Biotech Class 2023. The presentation will take place on Monday, May 15, at 4:20 p.m. in Leffey Room 2.

In addition, the leadership team of T-CURX, including Ulf, T-CURX' CFO, Tom Loeser and T-CURX' Global Head Business Development, Caroline Burger, will be available for meetings on both days of the conference.

For more information on this congress, please visit the conference's web-site at: https://conferences.biocentury.com/bioequity-europe